| Parent company | Pfizer |
| Type of work | Manufacturing |
| Reshoring category: | Reshoring |
| Total number of jobs (added or to be added): | 300 |
| Year reshoring announced: | 2022 |
| Year reshoring implemented or to be implemented: | 2023 |
| Capital investment ($): | 750 |
| Country(ies) from which reshored: | United States |
| City reshored to: | Kalamazoo |
| State(s) reshored to: | MI |
| If relevant, work nearshored to: | - |
| Industry(ies): | Chemicals |
| Product(s) reshored | Pharmaceuticals |
| What non-domestic negative factors made offshoring less attractive? | Difficulty of innovation/product differentiation, Supply chain interruption risk/Natural disaster risk/Political instability , Talent and Skilled labor availability |
| What domestic positive factors made reshoring more attractive? | Eco-system synergies, Higher productivity, Image/brand, Impact on domestic economy, Manufacturing/engineering joint innovation (R&D), Skilled workforce availability/training |
